Lamivudine as a Novel Clinical Effort for Rett Syndrome

NCT07640503 · clinicaltrials.gov ↗

PHASE2

Phase

ENROLLING_BY_INVITATION

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Rett Syndrome

Interventions

DRUG: Lamivudine

Sponsor

Maria Denise Fernandes Carvalho de Andrade

Collaborators

[object Object]